NAD+ Precursor Supplementation in Friedreich's Ataxia

Clinical trial NCT04817111 · COMPLETED

Trial details

NCT number: NCT04817111
Sponsor: Metro International Biotech, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Friedreich Ataxia

Start date: 2021-05-17
Primary completion: 2022-05-19
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.